1067 Companies
SIGA Technologies, a New York-based commercial-stage pharmaceutical company, is targeting the health security markets in the United States. The company's primary focus is on TPOXX, an oral antivira...
SIGA Annual Report 2023InflaRx N.V., a clinical-stage biopharmaceutical company specializing in C5a technology, is making waves in Germany and the United States with its unique inhibitors. C5a, an inflammatory mediator i...
InflaRx N.V. Annual Report 2023TG Therapeutics, Inc., a commercial biopharmaceutical company, is dedicated to acquiring, developing, and commercializing innovative treatments for B-cell diseases, such as BRIUMVI, an anti-CD20 mo...
TG Therapeutics Annual Report 2023CHF Solutions, Inc. is a medical device company that focuses on commercializing the Aquadex SmartFlow System, which provides aquapheresis therapy for patients with fluid overload who have failed di...
CHF Solutions, Inc. Annual Report 2020San Diego-based biotherapeutics company aTyr Pharma is focused on discovering and developing novel immunological pathways for the creation of new medicines. Its lead candidate, efzofitimod, is curr...
Lifecare Annual Report 2023BATM Advanced Communications Ltd is a technology company that specializes in real-time networking and cyber security solutions, as well as bio-medical and bio-waste treatment solutions. The company...
BATM Advanced Technologies Annual Report 2023PYC Therapeutics Limited is a biotechnology company based in Australia that focuses on the discovery and development of drug solutions in ribonucleic acid therapeutics. The company's preclinical de...
PYC Therapeutics Limited Annual Report 2023Apellis Pharmaceuticals Inc., a biopharmaceutical company, recently announced it is making strides in the discovery, development, and commercialization of therapeutic compounds for autoimmune and i...
Apellis Pharmaceuticals Annual Report 2023Baudax Bio, Inc., a pharmaceutical company specializing in hospital and acute-care products, has recently introduced their latest product, ANJESO (meloxicam), for the management of moderate to seve...
Baudax Bio, Inc. Annual Report 2021PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company that is focused on finding novel therapies for cardiovascular and cardiopulmonary diseases. Its pipeline includes bentracimab,...
PhaseBio Pharmaceuticals, Inc. Annual Report 2020Cross Country Healthcare, Inc. is a leading provider of talent management and consultative services for healthcare clients in the United States. The company operates in two distinct segments that i...
Cross Country Healthcare Annual Report 2023Lexington-based biotech firm, Frequency Therapeutics, Inc. is leveraging its innovative Progenitor Cell Activation approach to develop cutting-edge therapeutics that can help activate the body's na...
Frequency Therapeutics, Inc. Annual Report 2021GlycoMimetics, a clinical-stage biotech firm, is making strides in the field of glycobiology-based therapies for cancers and inflammatory diseases in the United States. Notably, the company is deve...
GlycoMimetics Inc Annual Report 2023Miami-based biopharmaceutical company Veru Inc. has made significant strides in the development of potential treatments for COVID-19, breast cancer, and prostate cancer. The company's product lineu...
Veru Annual Report 2023Biopharmaceutical company, Corbus Pharmaceuticals Holdings, Inc., has been making strides in its mission to combat serious illnesses through product development. The firm is currently working on CR...
Corbus Pharmaceuticals Holdings Annual Report 2023